MIPS Research Featured on the Cover of Oncotarget
April 20, 2018
Research from the Laboratory for Experimental and Molecular Neuroimaging (LEMNI) and Cellular Pathway Imaging Laboratory (CPIL) entitled "Targeted nanoparticle delivery of therapeutic antisense microRNAs presensitizes glioblastoma cells to lower effective doses of temozolomide in vitro and in a mouse model," was featured on the cover of the journal Oncotarget.
